Ask yourself this; what would a perfect developability assessment, earlier in the drug development process, mean to you?

Some of the leading drug developers are already carrying out an optimized developability assessment and are mitigating many of the challenges faced in later stages of development. Poor expression, misfolding or aggregation can cause significant delays in moving molecules forward into the manufacturing stage of development. These problems are frequently avoidable for the sake of relatively little investment early in the drug development process.

Developability of Biopharmaceuticals has been designed to support drug developers in reducing the cost, risk and time of development. The agenda focuses on engineering developability in early drug development to ‘design in’ desirable manufacturing properties, together with addressing safety and efficacy in early drug development to minimize costly attrition..

Why attend?

• Understand how to implement a detailed molecular assessment early in drug development, to mitigate costly attrition in later stages of design
• Learn how to use predictive tools to identify structural elements of proteins early and minimize the risk of instability in later stages of development
• Receive an update on the most cutting edge rational approaches for developability and manufacturability
• Get insights on appropriate analytical methods and their impact on allowing the assessment of multiple parameters relevant to biologics development 
• Explore cell lines to enhance existing systems of protein purification to enhance yield
• Optimize late stage formulation development by integrating manufacturability in early drug development

Who should attend?

Developability of Biopharmaceuticals is the world’s only meeting dedicated to integrating developability early in drug development. Meet and network with Directors, Associate Directors, Senior Scientists and Formulation experts to ensure maximum quality of discussions and add valuable contacts to your network

This means it is for:

• Drug Developers who are looking to optimize the potential of their candidates for drug manufacturability
• Solution providers who are looking to showcase their cutting edge platform technology to help fully integrate developability early in drug development
• Academic researchers looking for an insight into developability in the pharmaceutical industry, and who are looking for collaborative opportunities